Michel Pierre Ducreux
City Of Hope National Medical Center
2 papers in the Anchorcite directory, published between 2011 and 2020, cited 15,679 times in total.
ORCID profileResearch topics
- Cancer Treatment and Pharmacology · 1 paper
- Pancreatic and Hepatic Oncology Research · 1 paper
- Pancreatitis Pathology and Treatment · 1 paper
- Cancer Immunotherapy and Biomarkers · 1 paper
- Colorectal Cancer Treatments and Studies · 1 paper
- Hepatocellular Carcinoma Treatment and Prognosis · 1 paper
Frequent co-authors
- Thierry Conroy · 1 paper
- Françoise Desseigne · 1 paper
- Marc Ychou · 1 paper
- Olivier Bouché · 1 paper
- Rosine Guimbaud · 1 paper
- Y. Bécouarn · 1 paper
- Antoine Adenis · 1 paper
- Jean‐Luc Raoul · 1 paper
Papers
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine · 2011 · 7,975 citations
BACKGROUND: Data are lacking on the efficacy and safety of a combination chemotherapy regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) as compared with gemcitabine as first-line therapy in patients with metastatic pancreatic cancer. METHODS: We randomly assigned 342…
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular CarcinomaNew England Journal of Medicine · 2020 · 7,704 citations
BACKGROUND: The combination of atezolizumab and bevacizumab showed encouraging antitumor activity and safety in a phase 1b trial involving patients with unresectable hepatocellular carcinoma. METHODS: In a global, open-label, phase 3 trial, patients with unresectable hepatocellular carcinoma who had not…
Metadata from OpenAlex (CC0).